Abnormal hepatic transport of indocyanine green in Gilbert's syndrome

J. F. Martin, J. M. Vierling, Allan W. Wolkoff, B. F. Scharschmidt, J. Vergalla, J. G. Waggoner, P. D. Berk

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

The plasma fractional disappearance rate of indocyanine green (kICG, min -1) and the absolute hepatic ICG removal rate (VICG, mg per kg per min) were determined in 26 patients with Gilbert's syndrome (GS) and 19 normal control volunteers following intravenous administration of doses of 0.5, 2.0, 3.5, and 5.0 mg per kg of dye. The diagnosis of GS was based on studies of radiobilirubin kinetics in all cases and liver biopsy in 22 of 26 cases. The patients were further classified into 3 subgroups, based on patterns of sulfobromophthalein (BSP) kinetics as follows: GS I (15 patients) had normal BSP metabolism; GS II (5 patients) had a defect in BSP metabolism beyond the stage of initial hepatic uptake; and GS III (6 patients) had a defect in the initial hepatic uptake of BSP. Both kappaICG and VICG were significantly reduced, compared to normal controls, in the GS III group with defective BSP uptake, but did not differ significantly from normal in the GS I and GS II groups. Michaelis Menten analysis of the data indicated that VMAX for ICG uptake in the GS III group (1.2 ± 0.6 mg per min per kg) was significantly reduced compared to the previously established normal value of 3.6 ± 0.6 mg per min per kg; (P < 0.01). For the total population of 26 patients with Gilbert's syndrome, there was a highly significant correlation (r=0.77, P < 0.01) between kappaICG and λ21BSP, the fractional hepatic uptake rate for BSP. These studies confirm previous work indicating that patients with Gilbert's syndrome constitute a heterogeneous population with regard to defects in hepatic organic anion transport, some of the defects not being attributable to glucuronyl transferase deficiency. Future studies of Gilbert's syndrome must take into account the existence of these subgroups, since they may have different underlying pathogenetic mechanisms.

Original languageEnglish (US)
Pages (from-to)385-391
Number of pages7
JournalGastroenterology
Volume70
Issue number3
StatePublished - 1976
Externally publishedYes

Fingerprint

Gilbert Disease
Indocyanine Green
Liver
Sulfobromophthalein
Transferases
Intravenous Administration
Population
Anions

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Martin, J. F., Vierling, J. M., Wolkoff, A. W., Scharschmidt, B. F., Vergalla, J., Waggoner, J. G., & Berk, P. D. (1976). Abnormal hepatic transport of indocyanine green in Gilbert's syndrome. Gastroenterology, 70(3), 385-391.

Abnormal hepatic transport of indocyanine green in Gilbert's syndrome. / Martin, J. F.; Vierling, J. M.; Wolkoff, Allan W.; Scharschmidt, B. F.; Vergalla, J.; Waggoner, J. G.; Berk, P. D.

In: Gastroenterology, Vol. 70, No. 3, 1976, p. 385-391.

Research output: Contribution to journalArticle

Martin, JF, Vierling, JM, Wolkoff, AW, Scharschmidt, BF, Vergalla, J, Waggoner, JG & Berk, PD 1976, 'Abnormal hepatic transport of indocyanine green in Gilbert's syndrome', Gastroenterology, vol. 70, no. 3, pp. 385-391.
Martin JF, Vierling JM, Wolkoff AW, Scharschmidt BF, Vergalla J, Waggoner JG et al. Abnormal hepatic transport of indocyanine green in Gilbert's syndrome. Gastroenterology. 1976;70(3):385-391.
Martin, J. F. ; Vierling, J. M. ; Wolkoff, Allan W. ; Scharschmidt, B. F. ; Vergalla, J. ; Waggoner, J. G. ; Berk, P. D. / Abnormal hepatic transport of indocyanine green in Gilbert's syndrome. In: Gastroenterology. 1976 ; Vol. 70, No. 3. pp. 385-391.
@article{c2d7c3cbc36b4210b0616beb5249bd2b,
title = "Abnormal hepatic transport of indocyanine green in Gilbert's syndrome",
abstract = "The plasma fractional disappearance rate of indocyanine green (kICG, min -1) and the absolute hepatic ICG removal rate (VICG, mg per kg per min) were determined in 26 patients with Gilbert's syndrome (GS) and 19 normal control volunteers following intravenous administration of doses of 0.5, 2.0, 3.5, and 5.0 mg per kg of dye. The diagnosis of GS was based on studies of radiobilirubin kinetics in all cases and liver biopsy in 22 of 26 cases. The patients were further classified into 3 subgroups, based on patterns of sulfobromophthalein (BSP) kinetics as follows: GS I (15 patients) had normal BSP metabolism; GS II (5 patients) had a defect in BSP metabolism beyond the stage of initial hepatic uptake; and GS III (6 patients) had a defect in the initial hepatic uptake of BSP. Both kappaICG and VICG were significantly reduced, compared to normal controls, in the GS III group with defective BSP uptake, but did not differ significantly from normal in the GS I and GS II groups. Michaelis Menten analysis of the data indicated that VMAX for ICG uptake in the GS III group (1.2 ± 0.6 mg per min per kg) was significantly reduced compared to the previously established normal value of 3.6 ± 0.6 mg per min per kg; (P < 0.01). For the total population of 26 patients with Gilbert's syndrome, there was a highly significant correlation (r=0.77, P < 0.01) between kappaICG and λ21BSP, the fractional hepatic uptake rate for BSP. These studies confirm previous work indicating that patients with Gilbert's syndrome constitute a heterogeneous population with regard to defects in hepatic organic anion transport, some of the defects not being attributable to glucuronyl transferase deficiency. Future studies of Gilbert's syndrome must take into account the existence of these subgroups, since they may have different underlying pathogenetic mechanisms.",
author = "Martin, {J. F.} and Vierling, {J. M.} and Wolkoff, {Allan W.} and Scharschmidt, {B. F.} and J. Vergalla and Waggoner, {J. G.} and Berk, {P. D.}",
year = "1976",
language = "English (US)",
volume = "70",
pages = "385--391",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Abnormal hepatic transport of indocyanine green in Gilbert's syndrome

AU - Martin, J. F.

AU - Vierling, J. M.

AU - Wolkoff, Allan W.

AU - Scharschmidt, B. F.

AU - Vergalla, J.

AU - Waggoner, J. G.

AU - Berk, P. D.

PY - 1976

Y1 - 1976

N2 - The plasma fractional disappearance rate of indocyanine green (kICG, min -1) and the absolute hepatic ICG removal rate (VICG, mg per kg per min) were determined in 26 patients with Gilbert's syndrome (GS) and 19 normal control volunteers following intravenous administration of doses of 0.5, 2.0, 3.5, and 5.0 mg per kg of dye. The diagnosis of GS was based on studies of radiobilirubin kinetics in all cases and liver biopsy in 22 of 26 cases. The patients were further classified into 3 subgroups, based on patterns of sulfobromophthalein (BSP) kinetics as follows: GS I (15 patients) had normal BSP metabolism; GS II (5 patients) had a defect in BSP metabolism beyond the stage of initial hepatic uptake; and GS III (6 patients) had a defect in the initial hepatic uptake of BSP. Both kappaICG and VICG were significantly reduced, compared to normal controls, in the GS III group with defective BSP uptake, but did not differ significantly from normal in the GS I and GS II groups. Michaelis Menten analysis of the data indicated that VMAX for ICG uptake in the GS III group (1.2 ± 0.6 mg per min per kg) was significantly reduced compared to the previously established normal value of 3.6 ± 0.6 mg per min per kg; (P < 0.01). For the total population of 26 patients with Gilbert's syndrome, there was a highly significant correlation (r=0.77, P < 0.01) between kappaICG and λ21BSP, the fractional hepatic uptake rate for BSP. These studies confirm previous work indicating that patients with Gilbert's syndrome constitute a heterogeneous population with regard to defects in hepatic organic anion transport, some of the defects not being attributable to glucuronyl transferase deficiency. Future studies of Gilbert's syndrome must take into account the existence of these subgroups, since they may have different underlying pathogenetic mechanisms.

AB - The plasma fractional disappearance rate of indocyanine green (kICG, min -1) and the absolute hepatic ICG removal rate (VICG, mg per kg per min) were determined in 26 patients with Gilbert's syndrome (GS) and 19 normal control volunteers following intravenous administration of doses of 0.5, 2.0, 3.5, and 5.0 mg per kg of dye. The diagnosis of GS was based on studies of radiobilirubin kinetics in all cases and liver biopsy in 22 of 26 cases. The patients were further classified into 3 subgroups, based on patterns of sulfobromophthalein (BSP) kinetics as follows: GS I (15 patients) had normal BSP metabolism; GS II (5 patients) had a defect in BSP metabolism beyond the stage of initial hepatic uptake; and GS III (6 patients) had a defect in the initial hepatic uptake of BSP. Both kappaICG and VICG were significantly reduced, compared to normal controls, in the GS III group with defective BSP uptake, but did not differ significantly from normal in the GS I and GS II groups. Michaelis Menten analysis of the data indicated that VMAX for ICG uptake in the GS III group (1.2 ± 0.6 mg per min per kg) was significantly reduced compared to the previously established normal value of 3.6 ± 0.6 mg per min per kg; (P < 0.01). For the total population of 26 patients with Gilbert's syndrome, there was a highly significant correlation (r=0.77, P < 0.01) between kappaICG and λ21BSP, the fractional hepatic uptake rate for BSP. These studies confirm previous work indicating that patients with Gilbert's syndrome constitute a heterogeneous population with regard to defects in hepatic organic anion transport, some of the defects not being attributable to glucuronyl transferase deficiency. Future studies of Gilbert's syndrome must take into account the existence of these subgroups, since they may have different underlying pathogenetic mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=0017277704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017277704&partnerID=8YFLogxK

M3 - Article

C2 - 814028

AN - SCOPUS:0017277704

VL - 70

SP - 385

EP - 391

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 3

ER -